Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
about
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibitionCutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.The diverse roles of the TNF axis in cancer progression and metastasis.The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells.The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
P2860
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@ast
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@en
type
label
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@ast
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@en
prefLabel
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@ast
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@en
P2093
P2860
P50
P356
P1476
Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor
@en
P2093
C Enthammer
G Semenzato
M Cassatella
R Zambello
P2860
P2888
P304
P356
10.1038/BJC.1995.50
P407
P577
1995-02-01T00:00:00Z